PEAR - Pear Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

PEAR is currently covered by 4 analysts with an average price target of $2.33. This is a potential upside of $2.33 (0%) from yesterday's end of day stock price of $0.

Pear Therapeutics's activity chart (see below) currently has 3 price targets and 16 ratings on display. The stock rating distribution of PEAR is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for PEAR is $4, Lowest price target is $4, average price target is $2.33.

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 20-Mar-2023.

Best performing analysts who are covering PEAR - Pear Therapeutics:

Marie Thibault Keay Nakae Judah Frommer Charles Rhyee

Currently out of the existing stock ratings of PEAR, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

1

$0.99 (9900.00%)

7

1 years 8 days ago

0/3 (0%)

$0.79 (376.19%)

Buy

5

1 years 11 days ago

0/2 (0%)

$3 (150.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PEAR (Pear Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on PEAR (Pear Therapeutics) with a proven track record?

MARIE THIBAULT

Which analyst has the current lower performing score on PEAR (Pear Therapeutics) with a proven track record?

CHARLES RHYEE

Which analyst has the most public recommendations on PEAR (Pear Therapeutics)?

Marie Thibault works at BTIG and has 4 price targets and 3 ratings on PEAR

Which analyst is the currently most bullish on PEAR (Pear Therapeutics)?

Judah Frommer with highest potential upside - $0.99

Which analyst is the currently most reserved on PEAR (Pear Therapeutics)?

Marie Thibault with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?